Abstract
Background: Coronavirus disease (COVID-19) vaccine-related side effects have a deter-minant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the iden-tifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
| Original language | English |
|---|---|
| Article number | 7859 |
| Journal | International Journal of Environmental Research and Public Health |
| Volume | 18 |
| Issue number | 15 |
| DOIs | |
| Publication status | Published - 1 Aug 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COVID-19
- Cohort studies
- Cross-sectional studies
- Drug-related side effects and adverse reactions
- Health personnel
- Mass vaccination
- Prevalence
Fingerprint
Dive into the research topics of 'Covid-19 vaccines safety tracking (Covast): Protocol of a multi-center prospective cohort study for active surveillance of covid-19 vaccines’ side effects'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver